WALTHAM, Mass. — March 5, 2026 — Leads & Copy — Repligen Corporation (NASDAQ:RGEN) will participate in three upcoming investor conferences.
Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion at the Leerink Global Healthcare Conference in Miami on March 10, 2026, at 11:20 a.m. ET.
Garland will also participate in an analyst-led discussion at the Barclays 28th Annual Global Healthcare Conference in Miami on March 11, 2026, at 10:30 a.m. ET.
Olivier Loeillot, President and Chief Executive Officer, will participate in an analyst-led discussion at the 2026 KeyBanc Virtual Healthcare Forum on March 18, 2026, at 2:15 p.m. ET.
Live webcasts of the Leerink and KeyBanc presentations will be accessible through Repligen’s Investor Relations website and will be available for replay for a limited time following the events.
Repligen Corporation is a global life sciences company focused on bioprocessing technology. The company develops and commercializes bioprocessing technologies and systems for manufacturing biological drugs, serving biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Repligen’s focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins.
Repligen’s corporate headquarters are in Waltham, Massachusetts, and the majority of its manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands, and Sweden.
Source: Repligen Corporation
